| Développement International |
| |
 PDF |
| | |
| Experience in China |
| |
In China, RTI’s work in developing public-private partnerships, strengthening the capacity of nongovernmental organizations, and collaborating with national and subnational government has supported improvements in health; education; water and sanitation; and the environment. The following projects are examples of RTI’s work in China since 1998. |
| |
PDF |
| | |
| Finances Publiques et Croissance Economique |
| |
Brochure |
| | |
| RTI Health Solutions Overview Brochure |
| |
RTI-HS Brochure PDF |
| | |
| Emerge To Compete: Building Capacity for Economic Growth |
| |
RTI International’s Emerge to Compete (EtoC) initiative forges regionally focused networks of national and subnational economic development actors, including leading private and public institutions involved in regional development, investment, and trade. |
| |
PDF |
| | |
| Biostatistics |
| |
PDF |
| | |
| Database Analysis |
| |
PDF |
| | |
| Epidemiology |
| |
PDF |
| | |
| Epidemiology Literature Reviews |
| |
PDF |
| | |
| Health Economics |
| |
PDF |
| | |
| Health Preference Assessment |
| |
PDF |
| | |
| In Vitro ADME-Tox Services |
| |
With more than 30 years of experience conducting DMPK studies, RTI is a leader in the metabolism and pharmacokinetics of pharmaceuticals, chemicals, and other xenobiotics in mammalian systems. We offer a variety of standard in vitro ADME-tox studies that can be tailored to client
needs. |
| |
PDF |
| | |
| Medical Consulting and Writing |
| |
PDF |
| | |
| Medical Monitoring |
| |
PDF |
| | |
| Outcomes Research and Regulatory Strategy |
| |
PDF |
| | |
| Patient-Reported Outcomes |
| |
PDF |
| | |
| Pharmacovigilance |
| |
PDF |
| | |
| Pricing and Reimbursement |
| |
PDF |
| | |
| Product Value Dossiers |
| |
PDF |
| | |
| Prospective Observational Studies |
| |
PDF |
| | |
